Background illustration for clinical trials search

Paid Clinical Trials Meridian

Discover 212 paid clinical trials in Meridian, Idaho. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of BLB-201 RSV Vaccine in Infants and Children

for
Respiratory Syncytial Virus Infections
Location: Meridian ID, Rexburg ID, Modesto CA, Aurora CO,
Sponsor: Blue Lake Biotechnology Inc.

Sex: All

Age: 0 - 5

Code: NCT05655182

Phase1, Phase2, Recruiting

Effectiveness of Aurix Therapy in Pressure Ulcers

for
Pressure Ulcer
Location: Meridian ID, Visalia CA, Arcadia CA, Montebello CA,
Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352467

Recruiting

Effectiveness of Aurix Therapy in Diabetic Foot Ulcers

for
Diabetic Foot Ulcers
Location: Meridian ID, Visalia CA, Arcadia CA, Montebello CA,
Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352480

Recruiting

Effectiveness of Aurix Therapy in Venous Leg Ulcers

for
Venous Leg Ulcers
Location: Meridian ID, Bremerton WA, Visalia CA, Arcadia CA,
Sponsor: Nuo Therapeutics

Sex: All

Age: 18+

Code: NCT02352454

Recruiting

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

for
Chronic Spontaneous Urticaria (CSU)
Location: Meridian ID, Murray UT, Sandy City UT, Portland OR,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06868212

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

for
Overweight, Obesity
Location: Meridian ID, Layton UT, Escondido CA, Fargo ND,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 8 - 18

Code: NCT07253285

Phase3, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase2, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Eastern Cooperative Oncology Group

Sex: All

Age: 18 - 70+

Code: NCT06724237

Phase3, Recruiting

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18 - 39

Code: NCT03150693

Phase3, Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06998940

Phase3, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06686771

Phase3, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase3, Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

for
Castration-Sensitive Prostate Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT06931340

Phase3, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for
Locally Advanced Cervical Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Caldwell ID,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase2, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase3, Recruiting

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Meridian ID, Nampa ID, Boise ID, Fruitland ID,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06992427

Phase3, Recruiting